WikiMD's Wellness Encyclopedia WikiMD's Wellness Encyclopedia

Personal tools
  • Not logged in
  • Talk
  • Contributions
  • Create account
  • Log in

Navigation menu

Navigation
  • Main page
  • Current events
  • Recent changes
  • Popular pages
  • Random page
  • Upload file
  • Special pages
  • WikiMD St@tistics
Wellness matters
  • Wellness
  • Diet
  • Recipes
  • Weight loss diet
  • Medical weight loss NYC
  • Brooklyn weight loss
Encyclopedia
  • Health encyclopedia
  • Disease index
  • Health topics
  • Glossaries
  • Rare diseases
Directory
  • Doctor finder (US)
  • World Directory
Sister projects
  • Christian Encyclopedia
  • Medical weight loss NYC
  • Medical directory
Sponsors
  • NYC physician weight loss
  • Philadelphia medical weight loss
  • NYC sleep clinic
  • Philadelphia sleep clinic
  • Lose weight NYC
  • Indian vegetable farm NJ
  • W8MD weight loss centers
Contact
  • Contact us
Navigation
  • Speci@l PageS
Namespaces
TemplateDiscussion
Actions
Views
  • Read
  • Edit
  • View history
Toolbox
Toolbox
  • What links here
  • Related changes
  • Printable version
  • Permanent link
  • Page information
  • Cargo data

Template:Drug design

From WikiMD's Wellness Encyclopedia

Drug design
Steps in design
* Drug discovery
  • Hit to lead
  • Drug development
    • Preclinical
    • Clinical
      • Phases
Case studies of discovery
and development of drug classes
* 5α-Reductase inhibitors
  • ACE inhibitors
  • Angiotensin receptor blockers
  • Antiandrogens
  • Beta-blockers
  • Beta2 agonists
  • Cephalosporins
  • c-Met inhibitors
  • Cyclooxygenase 2 inhibitors
  • Dipeptidyl peptidase-4 inhibitors
  • Direct thrombin inhibitors
  • Direct Xa inhibitors
  • Dual serotonin and norepinephrine reuptake inhibitors
  • Selective serotonin reuptake inhibitors
  • Gliflozins
  • HIV-protease inhibitors
  • Integrase inhibitors
  • Lipase inhibitors
  • Memantine and related drugs
  • mTOR inhibitors
  • Neuraminidase inhibitors
  • Non-nucleoside reverse-transcriptase inhibitors
  • NS5A inhibitors
  • Nucleoside and nucleotide reverse-transcriptase inhibitors
  • PDE5 inhibitors
  • Proton pump inhibitors
  • Statins
  • Thalidomide and its analogs
  • Triptans
  • TRPV1 antagonists
  • Tubulin inhibitors
  • Bcr-Abl tyrosine-kinase inhibitors
  • Cannabinoid receptor antagonists
  • CCR5 receptor antagonists
  • Neurokinin 1 receptor antagonists
  • 5-HT3 antagonists
  • Melatonin receptor agonists
  • Renin inhibitors


Retrieved from "https://wikimd.com/index.php?title=Template:Drug_design&oldid=6445144"
  • Powered by MediaWiki
  • This page was last edited on 8 March 2025, at 18:49.
  • This page has been accessed 208 times.
  • Privacy policy
  • About WikiMD's Wellness Encyclopedia
  • Disclaimers